Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol, Florent Moulière
Cancer Cell (2019) Vol. 36, Iss. 4, pp. 350-368
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Laura Keller, Yassine Belloum, Harriet Wikman, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 345-358
Open Access | Times Cited: 327
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Hui Luo, Wei Wei, Ziyi Ye, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 5, pp. 482-500
Closed Access | Times Cited: 213
Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living
Ellen Heitzer, Lisa Auinger, Michael R. Speicher
Trends in Molecular Medicine (2020) Vol. 26, Iss. 5, pp. 519-528
Closed Access | Times Cited: 209
Cancer nanotechnology: current status and perspectives
Jessica A. Kemp, Young Jik Kwon
Nano Convergence (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 172
HPV post-infection microenvironment and cervical cancer
Yi Yuan, Xushan Cai, Fangrong Shen, et al.
Cancer Letters (2020) Vol. 497, pp. 243-254
Closed Access | Times Cited: 167
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Jonathan C. M. Wan, Katrin Heider, Davina Gale, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 548
Open Access | Times Cited: 156
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
Hui Zhou, Liyong Zhu, Jun Song, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 151
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Peter Peneder, Adrian M. Stütz, Didier Surdez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 144
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 119
Circulating cell-free DNA for cancer early detection
Qiang Gao, Qiang Zeng, Zhijie Wang, et al.
The Innovation (2022) Vol. 3, Iss. 4, pp. 100259-100259
Open Access | Times Cited: 117
Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
Xiaojing Du, Biwei Yang, Quanlin An, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100103-100103
Open Access | Times Cited: 110
The functional roles of the circRNA/Wnt axis in cancer
Chen Xue, Ganglei Li, Qiuxian Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 91
A clinician’s handbook for using ctDNA throughout the patient journey
Samantha O. Hasenleithner, Michael R. Speicher
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 81
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
Ellen Heitzer, Daan van den Broek, Marc G. Denis, et al.
ESMO Open (2022) Vol. 7, Iss. 2, pp. 100399-100399
Open Access | Times Cited: 78
DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation
Yunyun An, Xin Zhao, Ziteng Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
Tiago Brito-Rocha, Vera Constâncio, Rui Henrique, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 935-935
Open Access | Times Cited: 49
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies
Qiang Gao, Lin Ye, Binrong Li, et al.
Annals of Oncology (2023) Vol. 34, Iss. 5, pp. 486-495
Open Access | Times Cited: 47
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins
Kyriacos Felekkis, Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3403-3403
Open Access | Times Cited: 15
Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
Weilong Zhang, Baoying Ye, Yang Song, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion
Zijian Hu, Honghong Chen, Yanzhu Long, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103166-103166
Closed Access | Times Cited: 85
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
Florent Moulière, Christopher G. Smith, Katrin Heider, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 8
Open Access | Times Cited: 83
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
Guanhua Zhu, Yu Amanda Guo, Danliang Ho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 71
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
Irena Hudecova, Christopher G. Smith, Robert Hänsel‐Hertsch, et al.
Genome Research (2021) Vol. 32, Iss. 2, pp. 215-227
Open Access | Times Cited: 62
Cell-free DNA TAPS provides multimodal information for early cancer detection
Paulina Siejka-Zielińska, Jingfei Cheng, Felix Jackson, et al.
Science Advances (2021) Vol. 7, Iss. 36
Open Access | Times Cited: 60
Integrative Serum Metabolic Fingerprints Based Multi‐Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule Classification
Lin Wang, Mengji Zhang, Xufeng Pan, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top